Schroder Investment Management Group Sells 28,563 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Schroder Investment Management Group lessened its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,406,339 shares of the company's stock after selling 28,563 shares during the period. Schroder Investment Management Group owned approximately 0.83% of Option Care Health worth $31,868,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of OPCH. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Option Care Health by 84.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company's stock valued at $2,195,000 after purchasing an additional 32,142 shares during the period. Martingale Asset Management L P acquired a new position in shares of Option Care Health during the third quarter valued at $287,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Option Care Health during the third quarter valued at about $439,000. Atom Investors LP bought a new position in Option Care Health in the 3rd quarter valued at about $485,000. Finally, HighTower Advisors LLC raised its position in shares of Option Care Health by 10.0% during the 3rd quarter. HighTower Advisors LLC now owns 401,061 shares of the company's stock worth $12,514,000 after buying an additional 36,308 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Down 4.0 %

Shares of NASDAQ:OPCH traded down $1.40 during midday trading on Friday, hitting $33.54. 2,392,435 shares of the stock were exchanged, compared to its average volume of 1,734,150. The company has a market capitalization of $5.51 billion, a PE ratio of 28.18, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business's fifty day simple moving average is $32.97 and its two-hundred day simple moving average is $28.49.

Remove Ads

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of a number of research reports. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Barrington Research raised their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.